Weidung Bodil, Boström Gustaf, Toots Annika, Nordström Peter, Carlberg Bo, Gustafson Yngve, Littbrand Håkan
Department of Community Medicine and Rehabilitation, Geriatric Medicine, Umeå University, Umeå, Sweden.
Department of Community Medicine and Rehabilitation, Geriatric Medicine, Umeå University, Umeå, Sweden.
J Am Med Dir Assoc. 2015 Mar;16(3):208-14. doi: 10.1016/j.jamda.2014.09.004. Epub 2014 Oct 22.
Clinical trials and observational studies have produced contradictory results regarding the association of blood pressure (BP) and mortality in people aged 80 years or older. Gait speed at usual pace has been shown to moderate this association in a population of noninstitutionalized people aged 65 years or older. The aims of this study were to investigate the association of BP with all-cause mortality in a representative sample of people aged 85 years or older and to assess whether gait speed moderates this association.
DESIGN, SETTING, AND PARTICIPANTS: A total of 806 participants in the population-based prospective Umeå 85+/GERDA study aged 85, 90, and 95 years or older.
Gait speed at usual pace was measured over 2.4 m. The main outcome was hazard ratios (HRs) for all-cause mortality according to systolic and diastolic BP categories in the total sample and in faster-walking (≥0.5 m/s, n = 312) and slower-walking (<0.5 m/s, n = 433) subcohorts; the latter also included habitually nonwalking participants. Comprehensive adjustments were made for sociodemographic and clinical characteristics associated with death.
Mean age and baseline systolic and diastolic BP were 89.6 ± 4.6 years, 146.8 ± 23.9 mm Hg, and 74.8 ± 11.1 mm Hg, respectively. Most (n = 561 [69%]) participants were women, 315 (39%) were care facility residents, and 566 (70%) were prescribed BP-lowering drugs. Within 5 years, 490 (61%) participants died. In the total sample and slower-walking subcohort, systolic BP appeared to be inversely associated with mortality, although not independent of adjustments. Among faster-walking participants, mortality risk after adjustment was more than 2 times higher in those with systolic BP of 140 to 149 mm Hg (HR = 2.25, 95% confidence interval [CI] = 1.03-4.94) and 165 mm Hg or higher (HR = 2.13, 95% CI = 1.01-4.49), compared with systolic BP of 126 to 139 mm Hg. Mortality risk was also independently higher in faster-walking participants with diastolic BP higher than 80 mm Hg, compared with diastolic BP of 75 to 80 mm Hg (HR = 1.76, 95% CI = 1.07-2.90).
The gait speed threshold of 0.5 m/s may be clinically useful for the distinction of very old people with and without increased all-cause mortality risk due to elevated systolic and diastolic BP.
关于80岁及以上人群血压(BP)与死亡率之间的关联,临床试验和观察性研究得出了相互矛盾的结果。在65岁及以上的非机构化人群中,常速步态速度已被证明可调节这种关联。本研究的目的是调查85岁及以上人群的代表性样本中血压与全因死亡率之间的关联,并评估步态速度是否调节这种关联。
设计、设置和参与者:基于人群的前瞻性于默奥85+/GERDA研究中共有806名年龄在85、90和95岁及以上的参与者。
在2.4米的距离上测量常速步态速度。主要结局是总样本以及快走(≥0.5米/秒,n = 312)和慢走(<0.5米/秒,n = 433)亚组中根据收缩压和舒张压类别得出的全因死亡率风险比(HRs);后者还包括习惯性不走动的参与者。对与死亡相关的社会人口学和临床特征进行了全面调整。
平均年龄以及基线收缩压和舒张压分别为89.6±4.6岁、146.8±23.9毫米汞柱和74.8±11.1毫米汞柱。大多数(n = 561 [69%])参与者为女性,315名(39%)是护理机构居民,566名(70%)被开具了降压药。在5年内,490名(61%)参与者死亡。在总样本和慢走亚组中,收缩压似乎与死亡率呈负相关,尽管并非独立于调整因素。在快走参与者中,收缩压为140至149毫米汞柱(HR = 2.25,95%置信区间[CI] = 1.03 - 4.94)和165毫米汞柱及以上(HR = 2.13,95% CI = 1.01 - 4.49)的参与者,与收缩压为126至139毫米汞柱的参与者相比,调整后的死亡风险高出2倍以上。与舒张压为75至80毫米汞柱相比,快走参与者中舒张压高于80毫米汞柱时,死亡风险也独立更高(HR = 1.76,95% CI = 1.07 - 2.90)。
0.5米/秒的步态速度阈值可能在临床上有助于区分因收缩压和舒张压升高而全因死亡风险增加和未增加的高龄人群。